Azithromycin Before Induction

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Infections

In brief

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Key facts

Study ID

NCT06543290

Run by

Arrowhead Regional Medical Center

People needed

400

Starts

2023-08-07

Expected to finish

2026-08-07

Last updated by the study team

2025-09-12

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• • Third trimester of pregnancy defined as 28 0/7 weeks or more
• Singleton pregnancy
• Age 18-45
• Induction of labor initiated for medical or obstetrical reason or electively over 39 weeks of gestation
• No contraindication to vaginal delivery
• Reassuring fetal heart rate tracing
• Able and willing to provide informed consent

You may not qualify if…

• • Does not read or write in English or Spanish
• Unable or unwilling to give informed consent
• Use of antibiotic or antiviral agent within the last 7 days
• Evidence of active infection at the time of initiation of induction (patients with rectovaginal group B streptococcus positive results will be allowed to participate as it is a colonizing organism, unless they show evidence of active infection)
• Incarcerated Women
• Active substance abuse
• Age < 18

Where it is running

• Arrowhead Regional Medical Center — Colton, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.